A developer & maker of wearable wearable drug delivery devices, Sorrel Medical, made an announcement today regarding the appointment of Michael Ratigan as Chief Commercial Officer. Award-winning wearable drug delivery platform applications of Sorrel Medical have appealed momentous customer interest & the need for Sorrel Medical team expansion.
Michael will be leading the global business development & partnering initiatives, making the best use of his fifteen years of commercial development experience in the wearable injector drug delivery industry. Michael will be bringing more than 25 years of experience in managing sales, global business development, and marketing strategies.
Michael Ratigan stated that the rising healthcare trend towards self-administration & an upsurge in biologic drug formulations has shown a need for patient-centric wearable subcutaneous drug delivery solutions. Drug sterility barrier IP of Sorrel Medical & the platform’s capability of accommodating any size of standard vial & cartridge primary container considerably reduces development timelines & risk to clinical supply, offering a true commercially feasible clinical device.
He added that he was delighted to joining the Sorrel Medical to serve pharma partners, patients, & providers all over the world who need therapies best served by the drug delivery device class of wearable injectors.
Michael joins Sorrel from Phillips-Medisize, which is a Molex Firm & global leader in contract development & manufacturing services for the drug/medical delivery markets, where he served as VP Global Sales & Marketing. Before joining Phillips-Medisize, he served as Chief Commercial Officer and Senior VP at Unilife Corporation, which is a provider of injectable drug delivery systems. Michael also has an experience of serving as Worldwide Business Platform Leader at Becton Dickinson.
The Chief Executive Officer of Sorrel Medical, Andrei Yosef stated that Michael’s vast experience, knowledge, as well as, industry network make him the ideal person to lead our business development & partnering initiatives.